186 related articles for article (PubMed ID: 16112273)
21. Interleukin-4 receptor signaling pathways in asthma pathogenesis.
Chatila TA
Trends Mol Med; 2004 Oct; 10(10):493-9. PubMed ID: 15464449
[TBL] [Abstract][Full Text] [Related]
22. [Growth and differentiation of eosinophils--special reference to IL-5 and its receptor].
Akutsu I; Takatsu K
Nihon Rinsho; 1993 Mar; 51(3):557-64. PubMed ID: 8492427
[TBL] [Abstract][Full Text] [Related]
23. Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody.
Beyer BM; Ingram R; Ramanathan L; Reichert P; Le HV; Madison V; Orth P
J Mol Biol; 2008 Oct; 382(4):942-55. PubMed ID: 18708069
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22.
de Moura PR; Watanabe L; Bleicher L; Colau D; Dumoutier L; Lemaire MM; Renauld JC; Polikarpov I
FEBS Lett; 2009 Apr; 583(7):1072-7. PubMed ID: 19285080
[TBL] [Abstract][Full Text] [Related]
25. The design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modeling.
Feng J; Li Y; Shen B
Peptides; 2004 Jul; 25(7):1123-31. PubMed ID: 15245871
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a potent human interleukin-11 agonist.
Harmegnies D; Wang XM; Vandenbussche P; Leon A; Vusio P; Grötzinger J; Jacques Y; Goormaghtigh E; Devreese B; Content J
Biochem J; 2003 Oct; 375(Pt 1):23-32. PubMed ID: 12919066
[TBL] [Abstract][Full Text] [Related]
27. IL-5 and IL-5 receptor expression on human eosinophils in relation to eosinophil activation.
Chihara J; Capron M; Nakajima S
Biotechnol Ther; 1993; 4(3-4):271-83. PubMed ID: 8292975
[No Abstract] [Full Text] [Related]
28. Crystal structures of alpha-helical cytokine-receptor complexes: we've only scratched the surface.
Walter MR
Biotechniques; 2002 Oct; Suppl():46-8, 50-7. PubMed ID: 12395927
[TBL] [Abstract][Full Text] [Related]
29. The structure and binding mode of interleukin-18.
Kato Z; Jee J; Shikano H; Mishima M; Ohki I; Ohnishi H; Li A; Hashimoto K; Matsukuma E; Omoya K; Yamamoto Y; Yoneda T; Hara T; Kondo N; Shirakawa M
Nat Struct Biol; 2003 Nov; 10(11):966-71. PubMed ID: 14528293
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the interaction between human interleukin-5 and the soluble domain of its receptor using a surface plasmon resonance biosensor.
Morton TA; Bennett DB; Appelbaum ER; Cusimano DM; Johanson KO; Matico RE; Young PR; Doyle M; Chaiken IM
J Mol Recognit; 1994 Mar; 7(1):47-55. PubMed ID: 7986567
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-13 (IL-13) pathway.
Kelly-Welch A; Hanson EM; Keegan AD
Sci STKE; 2005 Jul; 2005(293):cm8. PubMed ID: 16030286
[TBL] [Abstract][Full Text] [Related]
32. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.
Wong CK; Li PW; Lam CW
Immunol Lett; 2007 Oct; 112(2):82-91. PubMed ID: 17719653
[TBL] [Abstract][Full Text] [Related]
33. Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2.
Li J; Tomkinson KN; Tan XY; Wu P; Yan G; Spaulding V; Deng B; Annis-Freeman B; Heveron K; Zollner R; De Zutter G; Wright JF; Crawford TK; Liu W; Jacobs KA; Wolfman NM; Ling V; Pittman DD; Veldman GM; Fouser LA
Int Immunopharmacol; 2004 May; 4(5):693-708. PubMed ID: 15120653
[TBL] [Abstract][Full Text] [Related]
34. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
[TBL] [Abstract][Full Text] [Related]
35. Negative modulation of signal transduction via interleukin splice variation.
Denessiouk KA; Denesyuk AI; Johnson MS
Proteins; 2008 May; 71(2):751-70. PubMed ID: 17979192
[TBL] [Abstract][Full Text] [Related]
36. IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22.
Wu PW; Li J; Kodangattil SR; Luxenberg DP; Bennett F; Martino M; Collins M; Dunussi-Joannopoulos K; Gill DS; Wolfman NM; Fouser LA
J Mol Biol; 2008 Oct; 382(5):1168-83. PubMed ID: 18675824
[TBL] [Abstract][Full Text] [Related]
37. The solution structure of the membrane-proximal cytokine receptor domain of the human interleukin-6 receptor.
Hecht O; Dingley AJ; Schwanter A; Ozbek S; Rose-John S; Grötzinger J
Biol Chem; 2006 Sep; 387(9):1255-9. PubMed ID: 16972794
[TBL] [Abstract][Full Text] [Related]
38. Identification of regions within the third FnIII-like domain of the IL-5Ralpha involved in IL-5 interaction.
Czabotar PE; Holland J; Sanderson CJ
Cytokine; 2000 Jul; 12(7):867-73. PubMed ID: 10880230
[TBL] [Abstract][Full Text] [Related]
39. Exploring biomolecular recognition using optical biosensors.
Canziani G; Zhang W; Cines D; Rux A; Willis S; Cohen G; Eisenberg R; Chaiken I
Methods; 1999 Oct; 19(2):253-69. PubMed ID: 10527730
[TBL] [Abstract][Full Text] [Related]
40. Beyond dimerization: a membrane-dependent activation model for interleukin-4 receptor-mediated signalling.
Weidemann T; Höfinger S; Müller K; Auer M
J Mol Biol; 2007 Mar; 366(5):1365-73. PubMed ID: 17223132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
